Two tremendous growth shares I’d buy today

Royston Wild discusses two stocks with delicious earnings potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Share pickers have failed to be excited by the latest trading statement from DCC (LSE: DCC), the sales, marketing and support services specialist last 1% lower from Thursday’s close.

The FTSE 100 firm advised in a reassuring update that at “what is still a very early stage in the financial year, the group reiterates its belief that the year ending 31 March 2018 will be another year of profit growth and development.”

DCC reported growth across each of its four divisions in the three months to June, with trading coming in line with expectations. The Dublin company noted that, should currency exchange rates remain where they are today for the remainder of the fiscal year, that it would experience a modest benefit in line with market predictions.

The fuel distributor said that, looking ahead, profits should be “significantly weighted” towards the second half of the fiscal period.

Growth great

It is worth pointing out at this stage that DCC has consistently grown earnings in recent years, and the City does not expect its proud growth record to cease any time soon. Bottom-line rises of 8% and 16% are forecast for the years to March 2018 and 2019 respectively.

Not only do the prospects for organic growth remain rosy, but DCC has the clout — as well as the appetite — to put a rocket under profits expansion through strategic M&A.

Indeed, the company commented today that “DCC’s strong and liquid balance sheet, leaves it well placed to continue the growth of its LPG, Retail & Oil, Healthcare and Technology divisions, in both existing and new geographies.” DCC cited the financial boost from its successful £450m fundraising in the US private placement debt market.

The company is on track to complete the acquisitions of Esso Retail Norway and Shell Hong Kong & Macau in the third and fourth quarters respectively, it added.

While a forward P/E multiple of 22.6 times may sail above the Footsie corresponding average of 15 times, I believe DCC’s exciting growth prospects merit such a rating.

M&A marvel

Like DCC, Porvair (LSE: PRV) has garnered a reputation as a dependable growth generator for years. And the number crunchers also expect the business to keep delivering — rises of 7% and 5% are chalked in for the periods ending November 2017 and 2019 respectively.

A prospective P/E ratio of 29.6 times may appear too rich for many share pickers. But in my opinion, the industrial filter manufacturer is worthy of this premium given the huge amounts of cash it is investing to bolster its position in fast-growing and niche areas.

Indeed, Porvair announced last month that it has started the current fiscal year well, the Norfolk business boasting of “a healthy order book going into the second half.” It commented that “organic growth continues to be driven by incremental new product introductions and capacity expansion,” and added that the recently-acquired laboratory consumables supplier J.G. Finneran has made an “excellent start” since its purchase in April.

Porvair has a terrific track record when it comes M&A, and further bolt-on buys would appear to be a matter of time. It noted that it has “has a strong balance sheet, a promising project pipeline and sees many opportunities for further growth ahead.” I for one expect earnings to continue stomping higher in the coming years.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK owns shares of Porvair. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »